TENAX THERAPEUTICS, INC. Restructuring Charges
TENAX THERAPEUTICS, INC. (TENX) reported Restructuring Charges of $0 for the 9-month period ending 2015-01-31, per its 10-Q filed 2015-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2016-03-14
- TENAX THERAPEUTICS, INC. restructuring charges for the quarter ending 2015-01-31 was $0.00.
- TENAX THERAPEUTICS, INC. restructuring charges for the quarter ending 2014-10-31 was $0.00.
- TENAX THERAPEUTICS, INC. restructuring charges for the quarter ending 2014-07-31 was $0.00.
- TENAX THERAPEUTICS, INC. restructuring charges for the quarter ending 2014-01-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. restructuring charges for fiscal 2013 was $220.72K.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month | Restructuring Charges 542 month | Restructuring Charges 545 month | Restructuring Charges 554 month | Restructuring Charges 557 month |
|---|---|---|---|---|---|---|---|---|
| 2015-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $0.00 derived: sum of 2 quarters · filed 2015-03-17 | $0.00 10-Q · filed 2015-03-17 | |||||
| 2014-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | ||||||
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | |||||||
| 2014-01-31 | $0.00 10-Q · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $220.72K 10-Q · filed 2014-03-17 | ||||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 | $0.00 10-Q · filed 2013-12-17 | $220.72K 10-Q · filed 2013-12-17 | |||||
| 2013-07-31 | $220.72K 10-Q · filed 2013-09-17 | |||||||
| 2013-04-30 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $2.94K derived: sum of 2 quarters · filed 2016-03-14 | $173.24K derived: sum of 3 quarters · filed 2016-03-14 | $220.72K 10-KT · filed 2016-03-14 | $220.72K 10-K · filed 2013-06-26 | |||
| 2013-01-31 | $2.94K 10-Q · filed 2014-03-17 | $173.24K derived: sum of 2 quarters · filed 2014-03-17 | $220.72K 10-Q · filed 2014-03-17 | $220.72K 10-Q · filed 2013-03-18 | ||||
| 2012-10-31 | $170.30K 10-Q · filed 2013-12-17 | $217.77K 10-Q · filed 2013-12-17 | $217.77K 10-Q · filed 2012-12-14 | |||||
| 2012-07-31 | $47.48K 10-Q · filed 2013-09-17 | $47.48K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |